(Q45148727)
Statements
Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions: we need processes in place to follow up suspicions about serious adverse events (English)
Graeme J Hankey
1 reference
John W Eikelboom
1 reference
Paul E Langton
Graeme J Hankey